Since the fall of the Soviet Union, injection drug abuse has become epidemic in Russia and the Ukraine. Beginning in 1995, a second epidemic, HIV-1 infection, has swept through Russia and the Ukraine. In the past six years, HIV-1 infections have increased from fewer than 2,000 to more than half a million in the two countries. This HIV-1 epidemic is unique in that almost all of the HIV-1 infections have occurred within communities of drug injectors. One feature of drug injection that is different between these countries and the rest of the world is the common use of homemade liquid opiate and amphetamine preparations. We seek to investigate the link between these two phenomena through an interdisciplinary study that investigates the virological and social consequences of liquid drug use. Because blood is sometimes used during the manufacture of liquid opiates, transmission of HIV-1 may be rampant if the virus survives the manufacturing process. We propose to test this possibility in the lab both simulating the drug preparations practices observed by field ethnographers during liquid drug manufacture and testing drug preparations themselves. In addition, we propose to investigate the extent to which the communal nature of liquid drug manufacture results in drug preparation and injection practices which place injectors in Russia and the Ukraine at great risk for HIV-1 infection. This study will be carried out by a multinational, multidisciplinary team of researchers building on the strength of a NIH-funded AIDS International Training and Research Program linking researchers in St. Petersburg to their colleagues at Yale University. With the addition of an international expert on liquid drug manufacturing and injection practices, this team is uniquely positioned to investigate the linkages between liquid drug use and the HIV-1 epidemic in Russian and Ukrainian drug injectors.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
1R01DA014713-01
Application #
6442324
Study Section
Special Emphasis Panel (ZDA1-WXG-F (27))
Program Officer
Hartsock, Peter
Project Start
2001-09-30
Project End
2005-08-31
Budget Start
2001-09-30
Budget End
2002-08-31
Support Year
1
Fiscal Year
2001
Total Cost
$482,387
Indirect Cost
Name
Yale University
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Heimer, Robert; Kinzly, Mark L; He, Helen et al. (2007) The effect of acids on the survival of HIV during drug injection. J Acquir Immune Defic Syndr 45:144-50
Uuskula, Anneli; Heimer, Robert; Dehovitz, Jack et al. (2006) Surveillance of HIV, hepatitis B virus, and hepatitis C virus in an estonian injection drug-using population: sensitivity and specificity of testing syringes for public health surveillance. J Infect Dis 193:455-7
Abdala, Nadia; Grund, Jean-Paul C; Tolstov, Yanis et al. (2006) Can home-made injectable opiates contribute to the HIV epidemic among injection drug users in the countries of the former Soviet Union? Addiction 101:731-7